AMGN

The 7 Best Healthcare Stocks to Buy for 2021

By Tom Taulli, InvestorPlace Contributor
Politics is a wildcard that can negatively impact healthcare stocks. But there are still many top companies with great prospects to consider.

The 7 Best Cheap Stocks to Kick Off 2021

By Tezcan Gecgil, InvestorPlace Contributor
Here are seven cheap stocks with solid businesses that may power portfolios in 2021

The 7 Best Dow Jones Stocks to Buy Now As You Ready for the Coming Year

By Josh Enomoto, InvestorPlace Contributor
For those who are put off by the extreme enthusiasm of this bull market, the usually reliable Dow Jones stocks offer much-needed balance. Here are seven to consider.

3 Under-Loved Biotech Stocks to Buy for Profits Into 2021

By Nicolas Chahine, InvestorPlace Contributor
Biotech stocks are vulnerable to headlines, but these three have too much potential to ignore. Own them for a swing trade into 2021.

7 Cutting-Edge Biotech Stocks for Tomorrow 

By Bret Kenwell, InvestorPlace Contributor
Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.

3 Newly Recruited Dow Jones Stocks to Trade

By Chris Tyler, InvestorPlace Contributor
In a market made up of individual companies, three fresh Dow Jones stocks are showing a close vote, with bulls and bears in on the action.

3 Reasons To Be Bullish On Biotech Giant Amgen

By Tom Taulli, InvestorPlace Contributor
The company has had some challenges. But when looking at the long-term, Amgen stock looks like a good play.

This Company is the Landlord of Life Sciences

By Neil George
Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.

4 California Stocks to Keep On Hold Until Post-Coronavirus

By Tezcan Gecgil, InvestorPlace Contributor
These four strong California stocks deserve your attention and further due diligence to be included in long-term portfolios.

This Stock Points to the Massive China Biotech Trend

By InvestorPlace Research Staff
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.

4 Healthcare Stocks to Buy For Coronavirus Innovation

By William Roth, InvestorPlace Market Strategist
As the world and the markets continue to grapple with the effects of the novel coronavirus outbreak, these innovative healthcare stocks to buy look poised for success.

7 Biotech Stocks to Buy and Hold in 2020

By Chris Lau, InvestorPlace Contributor
Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.

3 Healthcare Stocks Under Pressure from Bernie

By William Roth, InvestorPlace Market Strategist
These healthcare stocks are worth selling now as Sanders rises in the polls and given his stance that prices should be cut in half.

3 of the Best Healthcare Stocks to Buy in 2020

By Tyler Craig, Tales of a Technician
Here are three of the best healthcare stocks to buy, as the sector is flashing a 'buy-the-dip' setup to kick off the New Year.

U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020

By InvestorPlace Staff
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.

Stock Market Today: New Highs; Buy Micron, Nvidia?

By Bret Kenwell, InvestorPlace Contributor
Goldman Sachs analysts came out with three conviction buys on Monday. Here's what else happened in the stock market today.

3 Healthcare Stocks to Buy Before the End of 2019

By Tyler Craig, Tales of a Technician
The year-end success of the healthcare sector has led to several strong stocks to buy. Here are three of the best healthcare stocks to buy.

This $2.7 Billion Deal Is a Shot Across the Bow for Big Pharma

By InvestorPlace Research Staff
Folks who haven’t been paying attention to the absolutely huge potential happening in biotech stocks right now -- both in the U.S. and other parts of the world -- have been put on notice.

2020 Election Could Hurt Amgen Stock’s Healthy Dividend

By Dana Blankenhorn, InvestorPlace Contributor
The biggest risk to Amgen stock comes from health reform that might limit the number of drugs insurers pay for, creating price competition.
Load More